Annual Report 2024
At VIB, we are committed to pushing the boundaries of scientific discovery. Scientific excellence remains at the core of our mission. Our researchers study the molecular fundamentals of life, uncovering insights into disease mechanisms and plant biology. Their work lays the foundation for real-world impact and paves the way for innovative medical treatments and sustainable agricultural solutions.
As we reflect on 2024, we are pleased to highlight some of the many scientific breakthroughs that were accomplished by our research community across a wide variety of disciplines.
We revealed how the menstrual cycle influences breast cancer risk, we built synthetic nanopores that pave the way for tailored biosensors, and we refined microbiome biomarkers for colorectal cancer diagnosis. In addition, we discovered that, similar to people, plants go through a form of ‘puberty’ and with a little help from AI, we uncovered some of the secrets of beer flavors. This annual report showcases these and many other milestones.
This year, we strengthened our research environment by investing in cutting-edge technologies, and we merged VIB conferences and training into one solid program to foster knowledge exchange and career growth. Our Grand Challenges Program tackled pressing health and environmental issues, from new approaches in cancer treatment to sustainable agriculture. Through translational research, we advanced breakthroughs in immunology, neuroscience, and microbiology, ensuring that scientific discoveries move beyond the lab. VIB’s Innovation & Business team plays a crucial role in bridging the gap between science and society. By fostering partnerships, launching spin-offs, and licensing intellectual property, we are ensuring that groundbreaking research leads to tangible solutions.
This year, VIB successfully launched new biotech ventures, despite a challenging investment climate. Our growing network of bio-incubators in Ghent, Leuven, and Brussels provides start-ups with the infrastructure and support needed to scale their innovations. Through these initiatives, we are strengthening Flanders’ position as a key hub for life sciences and biotechnology.
VIB remains dedicated to responsible and ethical research. In animal studies, we continue to refine models and maximize the data derived from each experiment, reducing the number of animals needed while improving the quality of insights. Sustainability is also a growing priority, with concrete steps taken to minimize our environmental footprint and integrate eco-conscious practices into our daily operations.
The success of VIB is built on the dedication of our scientists, support staff, and partners. We take this opportunity to acknowledge every researcher, collaborator, and stakeholder who contributed to another year of remarkable achievements. By fostering curiosity and embracing bold ideas, we are shaping a future where science transforms lives.
Ajit Shetty, Chairman of the Board of Directors
Christine Durinx & Jérôme Van Biervliet, Managing Directors